Onsight Ventures

Onsight Ventures was founded in 2021 by Jasmin Güngör and Klaus Grössinger as a spin-off from the Hermann Hauser Family Office. Hermann Hauser, co-founder of Acorn and the ARM processor, serves on Onsight's advisory board. The firm's investment team includes professionals who previously worked at Hermann Hauser Investment GmbH, and the spin-off structure gives Onsight privileged access to deal flow from Hauser's decades-long European deep tech network.

Investment decisions are led by General Partners Jasmin Güngör and Klaus Grössinger, who co-founded the firm in 2021. A third General Partner, Dennis Feiler, is also listed on the firm's website. The advisory board — including Hermann Hauser, BioNTech board member Christoph Huber, and Martin Spitznagel — provides strategic guidance but day-to-day investment execution rests with the GP team.

Onsight structures its activity around direct early-stage equity investments in deep tech startups. Its disclosed portfolio of 17 companies consists entirely of direct positions across quantum computing, AI, photonics, and synthetic biology. The firm does not publicly describe any fund-of-funds activity or LP commitments to external managers.

The firm targets early-stage opportunities, from start-up through early venture rounds. Its portfolio includes companies founded as recently as 2024 (clock.bio, ZuriQ) and 2025 (Q.ANT), indicating a focus on seed and Series A stages. Onsight's website describes an approach centered on validating and scaling deep tech companies from their earliest institutional rounds.

Onsight states it has unparalleled access to proprietary deal flow, which it attributes to its spin-off from the Hermann Hauser family office and its location in Innsbruck. The firm benefits from the advisory network of Hermann Hauser, who invested in over 120 companies through Amadeus Capital, and from a pan-European network of university spin-outs — particularly in Germany, Austria, and the Nordics.

No separate philanthropic structures are disclosed on the firm's website or in public filings. The firm operates as a venture capital manager, Onsight Ventures Management GmbH, and does not list a foundation or charitable vehicle. Advisory board members like Christoph Huber and Hermann Hauser have personal philanthropic and scientific involvements, but these are distinct from the firm's investment operations.

Onsight combines the heritage of a single-family office spin-out with the structure of an independent early-stage venture manager. Its operational ties to Hermann Hauser Investment GmbH and the advisory involvement of Hauser and BioNTech co-founder Christoph Huber provide scientific and network advantages uncommon for a fund of its size in Tyrol. This hybrid architecture allows the firm to leverage family-office-grade access while investing on a deal-by-deal basis.